Importantly, increased expression levels of IL-8 were detected in the high-risk group in all NSCLC validation sets, and IL-8 was sufficient to trigger atrophy in C2C12 myotubes. The gene discussed is CXCL8; the disease is non-small cell lung carcinoma.